Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Katrin Schlag

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Medical Cannabis and Cannabinoids|October 22, 2021
An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?Anne Katrin Schlag
Expert Review of Pharmacoeconomics & Outcomes Research|February 23, 2024
Using real world evidence to optimize care: the case of medical cannabisAnne Katrin Schlag, David J Nutt, Michael Lynskey
International Review of Neurobiology|June 20, 2025
ForewordAnne Katrin Schlag, David J Nutt, Michael T Lynskey
Journal of Cannabis Research|July 30, 2025
The impact of cannabis use on ageing and longevity: a systematic review of research insightsSonam Nain, Niraj Singh, Anne Katrin Schlag, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
British Journal of Pharmacology|December 19, 2024
The Australia story: Current status and future challenges for the clinical applications of psychedelicsDavid J Nutt, Peter Hunt, Anne Katrin Schlag, et al.
Neuropharmacology|May 3, 2021
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeuticsAnne Katrin Schlag, Saoirse E O'Sullivan, Rayyan R Zafar, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medical Cannabis and Cannabinoids|October 22, 2021
An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK?Anne Katrin Schlag
Expert Review of Pharmacoeconomics & Outcomes Research|February 23, 2024
Using real world evidence to optimize care: the case of medical cannabisAnne Katrin Schlag, David J Nutt, Michael Lynskey
International Review of Neurobiology|June 20, 2025
ForewordAnne Katrin Schlag, David J Nutt, Michael T Lynskey
Journal of Cannabis Research|July 30, 2025
The impact of cannabis use on ageing and longevity: a systematic review of research insightsSonam Nain, Niraj Singh, Anne Katrin Schlag, et al.
BMJ Open|September 22, 2020
So near yet so far: why won't the UK prescribe medical cannabis?David Nutt, Steve Bazire, Lawrence D Phillips, et al.
British Journal of Pharmacology|December 19, 2024
The Australia story: Current status and future challenges for the clinical applications of psychedelicsDavid J Nutt, Peter Hunt, Anne Katrin Schlag, et al.
Neuropharmacology|May 3, 2021
Current controversies in medical cannabis: Recent developments in human clinical applications and potential therapeuticsAnne Katrin Schlag, Saoirse E O'Sullivan, Rayyan R Zafar, et al.
British Journal of Clinical Pharmacology|July 5, 2024
Authors' response to letter 'On the use of open-label studies for the evaluation of cannabis-based products for the treatment of long-COVID'Hannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Bjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.
British Journal of Clinical Pharmacology|December 18, 2023
Feasibility of a cannabidiol-dominant cannabis-based medicinal product for the treatment of long COVID symptoms: A single-arm open-label feasibility trialHannah Thurgur, Michael Lynskey, Anne Katrin Schlag, et al.
Pageof 2